Bernard Asselain

19.6k total citations
323 papers, 11.0k citations indexed

About

Bernard Asselain is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bernard Asselain has authored 323 papers receiving a total of 11.0k indexed citations (citations by other indexed papers that have themselves been cited), including 161 papers in Oncology, 118 papers in Cancer Research and 82 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bernard Asselain's work include Breast Cancer Treatment Studies (90 papers), Cancer Treatment and Pharmacology (38 papers) and Cancer Genomics and Diagnostics (36 papers). Bernard Asselain is often cited by papers focused on Breast Cancer Treatment Studies (90 papers), Cancer Treatment and Pharmacology (38 papers) and Cancer Genomics and Diagnostics (36 papers). Bernard Asselain collaborates with scholars based in France, United States and United Kingdom. Bernard Asselain's co-authors include Alain Fourquet, P Pouillart, Thierry Dorval, Laurence Desjardins, J.C. Durand, Xavier Sastre‐Garau, Philippe Beuzeboc, Rémy Salmon, Youlia Kirova and Anne Vincent‐Salomon and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Genetics.

In The Last Decade

Bernard Asselain

315 papers receiving 10.7k citations

Peers

Countries citing papers authored by Bernard Asselain

Since Specialization

Citations

This map shows the geographic impact of Bernard Asselain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Asselain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Asselain more than expected).

Fields of papers citing papers by Bernard Asselain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Asselain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Asselain. The network helps show where Bernard Asselain may publish in the future.

Co-authorship network of co-authors of Bernard Asselain

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Asselain. A scholar is included among the top collaborators of Bernard Asselain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Asselain. Bernard Asselain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	2022-RA-922-ESGO Histo-molecular characteristics of platinum-sensitive advanced endometrial cancer: data issued from the population included in the GINECO UTOLA study 2022 ·International Journal of Gynecological Cancer ·Florence Joly, (unknown), Dominique Vaur, Bernard Asselain, (unknown), Philippe Follana, (unknown), Michel Fabbro, Cyril Foa, (unknown), (unknown), Isabelle Cojean-Zelek, Antoine Arnaud, Sophie Roche, Anne‐Claire Hardy‐Bessard, (unknown), (unknown), Marie Ange Mouret‐Reynier, Karen Leroy, Jérôme Alexandre	0
2	Prognostic Biomarkers Used for Localised Prostate Cancer Management: A Systematic Review 2017 ·European Urology Focus ·Pierre‐Jean Lamy, Yves Allory, Anne‐Sophie Gauchez, Bernard Asselain, Philippe Beuzeboc, Patricia de Crémoux, Jacqueline Fontugne, (unknown), Christophe Hennequin, Jacqueline Lehmann‐Che, Christophe Massard, Ingrid Millet, T. Murez, Marie‐Hélène Schlageter, Olivier Rouvière, Diana Kassab‐Chahmi, François Rozet, Jean‐Luc Descotes, Xavier Rébillard	59
3	Stratégies thérapeutiques les 2 premières années après un diagnostic de cancer du poumon. ESCAP-2011-CPHG, étude en situation réelle réalisée dans les hôpitaux généraux français 2017 ·Revue des Maladies Respiratoires ·M Grivaux, François Goupil, Bernard Asselain, F Blanchon, T. Collon, D. Coëtmeur, C. Dayen, (unknown), Olivier Molinier, Martin Fortin, D. Debieuvre	7
4	Design and statistical principles of the SHIVA trial. 2015 ·PubMed ·Xavier Paolettí, Bernard Asselain, Maud Kamal, Nicolas Servant, (unknown), Ivan Bièche, Christophe Le Tourneau	1
5	Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast? 2015 ·Cancer/Radiothérapie ·Marick Laé, (unknown), (unknown), Bernard Asselain, Martine Trassard, Xavier Sastre, Youlia Kirova	38
6	Circulating tumor cell thresholds and survival scores in advanced metastatic breast cancer: The observational step of the CirCe01 phase III trial 2015 ·Cancer Letters ·Carole Hélissey, Frédérique Berger, Paul Cottu, Véronique Dièras, L. Mignot, Vincent Servois, Carole Bouleuc, Bernard Asselain, (unknown), (unknown), Jean‐Yves Pierga, François‐Clément Bidard	44
7	Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumab 2013 ·British Journal of Cancer ·(unknown), (unknown), Jacqueline Lehmann‐Che, Véronique Scott, (unknown), Bernard Asselain, J-Y Pierga, M. Marty, Patricia de Crémoux, F. Spyratos, Ivan Bièche	76
8	Treatment of Uveal Melanoma by Accelerated Proton Beam 2011 ·Developments in ophthalmology ·Laurence Desjardins, Livia Lumbroso‐Le Rouic, Christine Lévy‐Gabriel, Nathalie Cassoux, R. Dendale, A. Mazal, S. Delacroix, Xavier Sastre, Corine Plancher, Bernard Asselain	49
9	Five-year survival for lung cancer patients managed in general hospitals 2011 ·Revue des Maladies Respiratoires ·M Grivaux, Mahmoud Zureik, (unknown), Bernard Asselain, (unknown), J.-M. Chavaillon, A. Prudhomme, (unknown), (unknown), Bertrand Maury, Alexandra Bedossa, F Blanchon	32
10	LONG-TERM RESULTS OF LOW-DOSE PROTON BEAM THERAPY FOR CIRCUMSCRIBED CHOROIDAL HEMANGIOMAS 2009 ·Retina ·Christine Lévy‐Gabriel, Livia Lumbroso‐Le Rouic, (unknown), R. Dendale, S. Delacroix, Bernard Asselain, Jean‐Louis Habrand, Laurence Desjardins	34
11	Meta-analysis of the p53 Mutation Database for Mutant p53 Biological Activity Reveals a Methodologic Bias in Mutation Detection 2006 ·Clinical Cancer Research ·Thierry Soussi, Bernard Asselain, Dalil Hamroun, Shunsuke Kato, Chikashi Ishioka, Mireille Claustres, Christophe Béroud	58
12	CohorteKbp-2000-Cphg : évaluation des facteurs pronostiques de la survie du cancer bronchique primitif à 2 et 5 ans 2006 ·Revue des Maladies Respiratoires ·F Blanchon, M Grivaux, Mahmoud Zureik, (unknown), Bernard Asselain, François Lebas, (unknown), (unknown), (unknown), D. Coëtmeur, T. Collon, P. David, B. Delclaux, J. Piquet	12
13	Chromatin Assembly Factor-1, a Marker of Clinical Value to Distinguish Quiescent from Proliferating Cells 2004 ·Cancer Research ·Sophie E. Polo, Stamatios Theocharis, Jerzy Klijanienko, Alexia Savignoni, Bernard Asselain, Philippe Vielh, Geneviève Almouzni	75
14	Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes 2002 ·Journal of Clinical Oncology ·Roman Rouzier, Jean-Marc Extra, Jerzy Klijanienko, Marie-Christine Falcou, Bernard Asselain, Anne Vincent‐Salomon, Philippe Vielh, E. Bourstyn	265
15	Standards, Options et Recommandations pour la prise en charge de patientes atteintes de cancer invasif du col utérin (stade non métastatique) (version abrégée) 2002 ·Gynécologie Obstétrique & Fertilité ·M. Resbeut, (unknown), (unknown), Christine Haie‐Méder, A Bataillard, Catherine Lhommé, Bernard Asselain, (unknown), Alain Brémond, D. Castaigne, (unknown), G Houvenaeghel, Éric Lartigau, Éric Leblanc, Xavier Sastre‐Garau, (unknown), (unknown), (unknown), J Chauvergne	2
16	[Optic neuropathy after proton-beam therapy for malignant choroidal melanoma]. 2000 ·PubMed ·(unknown), Christine Lévy, (unknown), F D'Hermiès, E Frau, P Schlienger, (unknown), S. Delacroix, C. Nauraye, (unknown), R. Ferrand, A. Mazal, Bernard Asselain, Corine Plancher, Jean‐Louis Habrand, Laurence Desjardins	14
17	Infiltrating lobular carcinoma of the breast: Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns 1996 ·Cancer ·Xavier Sastre‐Garau, Michel Jouve, Bernard Asselain, Anne Vincent-Salomon, Philippe Beuzeboc, Thierry Dorval, J.C. Durand, (unknown), P Pouillart	327
18	Isolated axillary recurrences after conservative treatment of breast cancer 1996 ·European Journal of Cancer ·(unknown), Philippe Merviel, (unknown), Bernard Asselain, F. Campana, J.C. Durand	38
19	Prognostic value of steroid receptors after long-term follow-up of 2257 operable breast cancers 1996 ·British Journal of Cancer ·(unknown), Philippe Broët, H Magdelénat, J Delarue, F. Spyratos, (unknown), S Saez, (unknown), P Courrière, R Millon, Bernard Asselain	114
20	[Hepatic metastases of breast cancer. Analysis of the parameters which influence the response to chemotherapy]. 1985 ·PubMed ·P Pouillart, M Jouvet, T Palangié, E García-Giralt, (unknown), Thierry Dorval, Bernard Asselain	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact